We are live on ! Find out more
JMFC

J.M. Forbes & Co Portfolio holdings

AUM $1.27B
1-Year Est. Return 26.46%
This Fund
S&P 500
This Quarter Est. Return
+9.37%
1 Year Est. Return
+26.46%
3 Year Est. Return
+95.08%
5 Year Est. Return
+123.89%
10 Year Est. Return
+430.31%
AUM
$470M
AUM Growth
+$23.7M
Cap. Flow
-$4.64M
Cap. Flow %
-0.99%
Top 10 Hldgs %
31.15%
Holding
109
New
3
Increased
23
Reduced
48
Closed
3
Avg Time Held
15.1 quarters
Top 10 Avg Time Held
6 quarters
Top 20 Avg Time Held
8.9 quarters

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$8.91M
2
XYL icon
Xylem
XYL
+$5.13M
3
DIS icon
Walt Disney
DIS
+$4.35M
4
ECL icon
Ecolab
ECL
+$3.39M
5
TGT icon
Target
TGT
+$193K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$8.69M
2
EUFN icon
iShares MSCI Europe Financials ETF
EUFN
+$8.13M
3
SBUX icon
Starbucks
SBUX
+$5.21M
4
JD icon
JD.com
JD
+$3.03M
5
MSFT icon
Microsoft
MSFT
+$302K

Sector Composition

Rank Sector Weight
1 Healthcare 16.91%
2 Technology 16.12%
3 Financials 12.36%
4 Industrials 10.62%
5 Miscellaneous 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PG icon
1
Procter & Gamble
PG
$355B
$18.5M 3.93%
221,876
-996
-0.4% -$81.5K
2013 Q2
21 quarters
ADBE icon
2
Adobe
ADBE
$92B
$17.3M 3.67%
63,905
-401
-0.6% -$103K
2013 Q2
21 quarters
CRM icon
3
Salesforce
CRM
$196B
$16.5M 3.51%
103,929
-6
-0% -$890
2014 Q4
15 quarters
V icon
4
Visa
V
$744B
$14.7M 3.13%
98,251
-34
-0% -$4.83K
2015 Q1
14 quarters
ZTS icon
5
Zoetis
ZTS
$30.7B
$14.3M 3.04%
156,018
-412
-0.3% -$36.5K
2013 Q2
21 quarters
PFE icon
6
Pfizer
PFE
$162B
$14.2M 3.03%
340,529
+228
+0.1% +$8.78K
2013 Q2
21 quarters
NEE icon
7
NextEra Energy
NEE
$163B
$14.1M 3%
336,380
-1,552
-0.5% -$66.1K
2013 Q2
21 quarters
JNJ icon
8
Johnson & Johnson
JNJ
$599B
$13M 2.77%
94,252
-315
-0.3% -$41.9K
2013 Q2
21 quarters
EMR icon
9
Emerson Electric
EMR
$91.2B
$12M 2.55%
156,718
+144
+0.1% +$10.6K
2013 Q2
21 quarters
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.33T
$11.9M 2.53%
196,900
-700
-0.4% -$42.4K
2015 Q4
11 quarters
USB icon
11
US Bancorp
USB
$88.6B
$11.6M 2.47%
219,938
-998
-0.5% -$52.9K
2013 Q2
21 quarters
IJR icon
12
iShares Core S&P Small-Cap ETF
IJR
$103B
$11.3M 2.41%
130,093
+425
+0.3% +$37.2K
2017 Q4
3 quarters
MRK icon
13
Merck
MRK
$350B
$11.1M 2.36%
163,932
-464
-0.3% -$29.6K
2013 Q2
21 quarters
AAPL icon
14
Apple
AAPL
$4.98T
$10.9M 2.32%
193,220
-2,112
-1% -$110K
2013 Q2
21 quarters
CSCO icon
15
Cisco
CSCO
$454B
$10.6M 2.26%
218,339
+579
+0.3% +$26K
2016 Q2
9 quarters
ABT icon
16
Abbott
ABT
$178B
$10.6M 2.26%
144,636
+135,643
+1,508% +$8.91M
2013 Q2
21 quarters
JPM icon
17
JPMorgan Chase
JPM
$881B
$10.6M 2.24%
93,500
+44
+0% +$5K
2016 Q4
7 quarters
PNC icon
18
PNC Financial Services
PNC
$87.6B
$10.4M 2.21%
76,233
+110
+0.1% +$15.6K
2013 Q2
21 quarters
UNP icon
19
Union Pacific
UNP
$168B
$10.2M 2.17%
62,550
-495
-0.8% -$74.5K
2013 Q2
21 quarters
XOM icon
20
ExxonMobil
XOM
$716B
$10M 2.13%
117,680
-1,496
-1% -$122K
2013 Q2
21 quarters
RDS.B
21
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$9.84M 2.09%
138,655
-235
-0.2% -$16.3K
2016 Q3
8 quarters
VZ icon
22
Verizon
VZ
$181B
$9.37M 1.99%
175,579
-236
-0.1% -$12.5K
2013 Q2
21 quarters
HXL icon
23
Hexcel
HXL
$6.51B
$9.11M 1.94%
135,882
-324
-0.2% -$22K
2013 Q2
21 quarters
PX icon
24
DELISTED
Praxair Inc
PX
$8.95M 1.9%
55,675
+98
+0.2% +$15.7K
2013 Q2
21 quarters
LOW icon
25
Lowe's Companies
LOW
$106B
$8.88M 1.89%
77,347
+228
+0.3% +$23.8K
2016 Q2
9 quarters

Similar funds

J.M. Forbes & Co's Q3 2018 Portfolio in Review

As of Q3 2018, J.M. Forbes & Co held 109 positions worth $470M, up 5.3% from $447M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

J.M. Forbes & Co's Q3 2018 filing shows 3 new, 23 increased, 48 reduced and 3 closed positions. Its largest new stake was Xylem: 68,654 shares worth $5.48M. The largest sale was AbbVie, an estimated $8.69M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • J.M. Forbes & Co's largest Q3 2018 buy was Xylem: 68,654 shares worth $5.48M.
  • J.M. Forbes & Co added most to Abbott in Q3 2018, an estimated $8.91M increase.
  • J.M. Forbes & Co's biggest Q3 2018 reduction was AbbVie, cutting an estimated $8.69M.
  • J.M. Forbes & Co fully exited iShares MSCI Europe Financials ETF in Q3 2018, selling an estimated $8.13M.
  • J.M. Forbes & Co's ten largest holdings make up 31% of its $470M portfolio in Q3 2018.
  • J.M. Forbes & Co opened 3 new positions and closed 3 in Q3 2018.
  • J.M. Forbes & Co's portfolio value rose 5.3% quarter-over-quarter to $470M.

Based on J.M. Forbes & Co's 13F filing for Q3 2018, filed 2 Nov 2018.